Calderaro Charles III bought RNA
January 6, 2025 · Form 4 insider transaction
Calderaro Charles III bought 80,000 shares of Atrium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
80,000
Price
$0.00
Total value
N/A
InsiderCalderaro Charles III
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2025
Filing dateJanuary 8, 2025
Shares owned after80,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests as follows: 1/4 of the shares underlying the option vest on the first anniversary of January 6, 2025, and 1/48 of the total shares underlying the option shall vest in equal monthly installments thereafter.